missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
R&D Systems™ Recombinant Human Noggin GMP Protein, CF
Beskrivning
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.0200-0.240 μg/mL.
Specifikationer
Specifikationer
| Tillträdesnummer | Q13253.1 |
| För användning med (applikation) | Bioactivity |
| Formulering | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate with Trehalose. |
| Gen-ID (Entrez) | 9241 |
| Molekylvikt (g/mol) | Observed: 27 kDa, under reducing conditions., Theroretical: 23 kDa (monomer) |
| Kvantitet | 1 mg |
| Källa | E. coli-derived human Noggin protein Gln28 - Cys232 with an N-terminal Met Produced using non-animal reagents in an animal-free laboratory. Manufactured and tested under cGMP guidelines. |
| Förvaringskrav | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. A minimum of 12 months when stored at ≤-20°C as supplied. Refer to lot specific COA for the Use by Date. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, ≤-20°C under sterile conditions after reconstitution. |
| Endotoxinkoncentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | NOG, noggin, SYM1, symphalangism 1 (proximal), synostoses (multiple) syndrome 1, SYNS1, SYNS1A |
| Visa mer |
Produkttitel
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.
Hittar du en möjlighet till förbättring?